Literature DB >> 15342391

Growth and survival mechanisms associated with perineural invasion in prostate cancer.

Gustavo E Ayala1, Hong Dai, Michael Ittmann, Rile Li, Michael Powell, Anna Frolov, Thomas M Wheeler, Timothy C Thompson, David Rowley.   

Abstract

Perineural invasion (PNI) is the major mechanism of prostate cancer spread outside the prostate. Apoptotic and proliferation indices were determined in PNI cells using the PNI in vitro model and human PNI in tissue microarrays. RNA was extracted from the PNI model and controls and evaluated by cDNA microarray analysis. Differential expression of candidate genes was confirmed by real-time quantitative PCR, fluorescence, and immunohistochemistry using tissue microarrays. Genistein and BAY 11-7085 were added to the supernatant of cocultures and controls in microchamber cultures. The significance of nuclear factor kappaB (NFkappaB) nuclear translocation in human PNI was analyzed using Kaplan-Meier analysis. An increase in proliferation and a decrease in apoptosis were observed in human PNI cells and the PNI model as compared with controls. Three of 15 genes up-regulated in the cDNA microarray were involved in the apoptosis signaling pathway (NFkappaB), and its downstream targets defender against cell death 1 and PIM-2. The increase was corroborated by real-time quantitative PCR and immunofluorescence. NFkappaB nuclear translocation was seen in the in vitro model and human tissues, where strong nuclear expression was associated with a decrease in recurrence-free survival. Addition of genistein and BAY 11-7085 resulted in a decrease in NFkappaB, PIM-2 and defender against cell death 1 as well as a reversal of the inhibition of apoptosis. This is the first description of a biological mechanism and functional significance of PNI. Cancer cells in a perineural location acquire a survival and growth advantage using a NFkappaB survival pathway. Targeting PNI might help detain local spread of the tumor and influence survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342391     DOI: 10.1158/0008-5472.CAN-04-0838

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  74 in total

1.  Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.

Authors:  Benjamin T Ristau; Jeffrey J Tomaszewski; Yi-Fan Chen; Marnie Bertolet; Elen Woldemichael; Joel B Nelson
Journal:  World J Urol       Date:  2014-11-01       Impact factor: 4.226

2.  GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.

Authors:  Guru Sonpavde; Timothy C Thompson; Rajul K Jain; Gustavo E Ayala; Shinji Kurosaka; Kohei Edamura; Ken-ichi Tabata; Chengzhen Ren; Alexei A Goltsov; Martha P Mims; Teresa G Hayes; Michael M Ittmann; Thomas M Wheeler; Adrian Gee; Brian J Miles; Dov Kadmon
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

Review 3.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

4.  Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.

Authors:  Stefano Cecchini; Camilo Correa-Gallego; Vikram Desphande; Matteo Ligorio; Abdulmetin Dursun; Jennifer Wargo; Carlos Fernàndez-del Castillo; Andrew Louis Warshaw; Cristina Rosa Ferrone
Journal:  J Gastrointest Surg       Date:  2011-10-18       Impact factor: 3.452

Review 5.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

6.  Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis.

Authors:  Yang Meng; Yan-Biao Liao; Peng Xu; Wu-Ran Wei; Jia Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression.

Authors:  Yi Cai; Jianghua Wang; Rile Li; Gustavo Ayala; Michael Ittmann; Mingyao Liu
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

9.  Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.

Authors:  Yi Ding; Dandan He; Diego Florentin; Anna Frolov; Sue Hilsenbeck; Michael Ittmann; Dov Kadmon; Brian Miles; David Rowley; Gustavo Ayala
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

10.  Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.

Authors:  Robyn L Prueitt; Ming Yi; Robert S Hudson; Tiffany A Wallace; Tiffany M Howe; Harris G Yfantis; Dong H Lee; Robert M Stephens; Chang-Gong Liu; George A Calin; Carlo M Croce; Stefan Ambs
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.